EPS Bio Technology Corp. - Laporan Laba Rugi (TTM)

EPS Bio Technology Corp.
TW ˙ TPEX
NT$ 23.75 ↑0.10 (0.42%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi EPS Bio Technology Corp. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 497 478 459 435 451 480 504 485 506 463 442 454 424 470 477 498 485 451 478 469
Change (%) -3.83 -3.89 -5.14 3.66 6.40 5.04 -3.77 4.29 -8.46 -4.70 2.72 -6.63 11.00 1.50 4.45 -2.70 -7.00 6.00 -1.82
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 356 343 334 322 347 360 380 366 379 356 335 348 325 354 357 373 355 355 385 383
Change (%) -3.65 -2.55 -3.69 7.93 3.55 5.69 -3.65 3.62 -6.18 -5.93 4.00 -6.71 9.08 0.69 4.43 -4.74 -0.06 8.59 -0.71
% of Revenue 71.65 71.79 72.78 73.89 76.93 74.88 75.34 75.44 74.95 76.82 75.83 76.78 76.72 75.39 74.79 74.77 73.20 78.66 80.58 81.49
Gross Operating Profit 141 135 125 114 104 121 124 119 127 107 107 105 99 116 120 126 130 96 93 87
Change (%) -4.28 -7.28 -9.01 -8.42 15.89 3.09 -4.14 6.35 -15.30 -0.62 -1.33 -6.38 17.34 3.98 4.52 3.37 -25.94 -3.56 -6.40
% of Revenue 28.35 28.21 27.22 26.11 23.07 25.12 24.66 24.56 25.05 23.18 24.17 23.22 23.28 24.61 25.21 25.23 26.80 21.34 19.42 18.51
SG&A 60 60 57 55 54 55 59 59 60 61 55 57 54 58 60 60 62 57 60 61
Change (%) 0.35 -4.69 -4.34 -0.91 1.73 5.86 0.77 1.56 0.96 -9.77 4.42 -5.74 7.09 3.54 0.68 3.80 -7.79 5.13 0.69
% of Revenue 12.08 12.61 12.50 12.61 12.05 11.52 11.61 12.16 11.84 13.06 12.37 12.57 12.69 12.24 12.49 12.04 12.84 12.73 12.63 12.95
R&D 32 30 32 32 32 32 31 31 31 31 31 32 32 33 33 34 34 33 34 34
Change (%) -5.74 5.04 -0.26 0.19 1.19 -3.32 -0.80 -0.49 0.25 1.67 1.63 1.11 2.99 -0.07 2.36 0.11 -1.73 1.05 0.21
% of Revenue 6.49 6.36 6.95 7.31 7.07 6.72 6.19 6.38 6.08 6.66 7.11 7.03 7.62 7.07 6.96 6.82 7.01 7.41 7.07 7.21
OpEx 448 433 423 408 434 447 470 456 470 447 421 437 411 445 450 467 451 446 479 477
Change (%) -3.26 -2.32 -3.52 6.14 3.15 5.06 -2.91 3.08 -4.85 -5.93 3.88 -6.01 8.34 1.00 3.78 -3.29 -1.25 7.58 -0.47
% of Revenue 90.23 90.75 92.24 93.81 96.05 93.12 93.14 93.97 92.88 96.54 95.30 96.38 97.03 94.70 94.24 93.63 93.06 98.80 100.28 101.65
Operating Income 49 44 36 27 18 33 35 29 36 16 21 16 13 25 28 32 34 5 -1 -8
Change (%) -9.03 -19.30 -24.36 -33.86 85.40 4.71 -15.45 23.24 -55.60 29.54 -20.94 -23.20 97.84 10.39 15.44 6.06 -83.97 -124.49 485.86
% of Revenue 9.77 9.25 7.76 6.19 3.95 6.88 6.86 6.03 7.12 3.46 4.70 3.62 2.97 5.30 5.76 6.37 6.94 1.20 -0.28 -1.65
Interest Expense -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2
Change (%) -2.63 -1.92 -0.89 -0.81 -1.18 -1.24 -1.02 -0.28 0.23 0.47 0.28 -0.14 -0.56 -0.80 -1.04 -1.10 -0.96 -2.05 -1.89
% of Revenue -0.47 -0.48 -0.49 -0.51 -0.49 -0.45 -0.43 -0.44 -0.42 -0.46 -0.49 -0.47 -0.51 -0.45 -0.44 -0.42 -0.43 -0.46 -0.42 -0.42
Net Income 34 32 22 15 7 19 26 25 36 25 25 24 20 21 30 34 30 17 -0 -14
Change (%) -5.44 -30.40 -34.06 -54.19 179.61 42.17 -5.72 45.86 -30.41 -0.38 -3.03 -20.14 7.28 44.67 12.51 -11.33 -42.87 -102.14 3,744.26
% of Revenue 6.75 6.64 4.81 3.34 1.48 3.88 5.25 5.15 7.20 5.47 5.72 5.40 4.62 4.46 6.36 6.85 6.25 3.84 -0.08 -3.03

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista